Literature DB >> 18830188

Dissociative symptoms and neuroendocrine dysregulation in depression.

Petr Bob1, Peter Fedor-Freybergh, Denisa Jasova, Gustav Bizik, Marek Susta, Josef Pavlat, Tomas Zima, Hana Benakova, Jiri Raboch.   

Abstract

BACKGROUND: Dissociative symptoms are traditionally attributed to psychological stressors that produce dissociated memories related to stressful life events. Dissociative disorders and dissociative symptoms including psychogenic amnesia, fugue, dissociative identity-disorder, depersonalization, derealization and other symptoms or syndromes have been reported as an epidemic psychiatric condition that may be coexistent with various psychiatric diagnoses such as depression, schizophrenia, borderline personality disorder or anxiety disorders. According to recent findings also the somatic components of dissociation may occur and influence brain, autonomic and neuroendocrine functions. At this time there are only few studies examining neuroendocrine response related to dissociative symptoms that suggest significant dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis. The aim of the present study is to perform examination of HPA axis functioning indexed by basal cortisol and prolactin and test their relationship to psychic and somatoform dissociative symptoms. MATERIAL/
METHODS: Basal cortisol and prolactin and psychic and somatoform dissociative symptoms were assessed in 40 consecutive inpatients with diagnosis of unipolar depression mean age 43.37 (SD=12.21).
RESULTS: The results show that prolactin and cortisol as indices of HPA axis functioning manifest significant relationship to dissociative symptoms. Main results represent highly significant correlations obtained by simple regression between psychic dissociative symptoms (DES) and serum prolactin (R=0.55, p=0.00027), and between somatoform dissociation (SDQ-20) and serum cortisol (R=-0.38, p=0.015).
CONCLUSIONS: These results indicate relationship between HPA-axis reactivity and dissociative symptoms in unipolar depressive patients that could reflect passive coping behavior and disengagement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830188

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  9 in total

Review 1.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

2.  Expression of corticosteroid-binding globulin in human astrocytoma cell line.

Authors:  Larissa Pusch; Sonja Wegmann; Jack D Caldwell; Gustav F Jirikowski
Journal:  Cell Mol Neurobiol       Date:  2009-01-27       Impact factor: 5.046

3.  An integrative network analysis framework for identifying molecular functions in complex disorders examining major depressive disorder as a test case.

Authors:  Anup Mammen Oommen; Stephen Cunningham; Páraic S O'Súilleabháin; Brian M Hughes; Lokesh Joshi
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

4.  Endogenous reward mechanisms and their importance in stress reduction, exercise and the brain.

Authors:  Tobias Esch; George B Stefano
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

5.  Negative Emotional Arousal Impairs Associative Memory Performance for Emotionally Neutral Content in Healthy Participants.

Authors:  Jonathan Guez; Rotem Saar-Ashkenazy; Liran Mualem; Matan Efrati; Eldad Keha
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

6.  Plasma cortisol in Alzheimer's disease with or without depressive symptoms.

Authors:  Martina Zvěřová; Zdeněk Fišar; Roman Jirák; Eva Kitzlerová; Jana Hroudová; Jiří Raboch
Journal:  Med Sci Monit       Date:  2013-08-19

7.  Dissociative symptoms are associated with reduced neuropsychological performance in patients with recurrent depression and a history of trauma exposure.

Authors:  Melissa Parlar; Paul A Frewen; Carolina Oremus; Ruth A Lanius; Margaret C McKinnon
Journal:  Eur J Psychotraumatol       Date:  2016-02-25

Review 8.  Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.

Authors:  C Gragnoli; G M Reeves; J Reazer; T T Postolache
Journal:  Transl Psychiatry       Date:  2016-04-19       Impact factor: 6.222

9.  Hypothalamus-Pituitary-Adrenal Axis Hypersuppression Is Associated with Gastrointestinal Symptoms in Major Depression.

Authors:  Pontus Karling; Mikael Wikgren; Rolf Adolfsson; Karl-Fredrik Norrback
Journal:  J Neurogastroenterol Motil       Date:  2016-04-30       Impact factor: 4.924

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.